Neterton Syndrome
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab (NCT07151508) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-12-19 |
Track Neterton Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.